Literature DB >> 20005948

A two-layer diffusive model for describing the variability of transdermal drug permeation.

Victor M Meidan1, David Pritchard.   

Abstract

There is mounting evidence that the permeability coefficients (k(p)) that describe any given transdermal drug permeation process generally follow some form of positively skewed, non-symmetrical distribution rather than a simple normal distribution. Yet a suitable theoretical treatment of this area has not been undertaken to date. In this paper, we describe a two-layer model that can explain five drugs'k(p) variabilities as measured in two previously published papers. The model shows why rapidly permeating drugs would tend to exhibit more symmetrical k(p) distributions while progressively more slowly permeating drugs would tend to exhibit progressively more positively skewed k(p) distributions. Future research should take this effect into account when comparing the flux variabilities of hydrophilic and lipophilic drugs. (c) 2009 Elsevier B.V. All rights reserved.

Mesh:

Substances:

Year:  2009        PMID: 20005948     DOI: 10.1016/j.ejpb.2009.12.003

Source DB:  PubMed          Journal:  Eur J Pharm Biopharm        ISSN: 0939-6411            Impact factor:   5.571


  3 in total

1.  Effect of direction (epidermis-to-dermis and dermis-to-epidermis) on the permeation of several chemical compounds through full-thickness skin and stripped skin.

Authors:  Takeshi Oshizaka; Hiroaki Todo; Kenji Sugibayashi
Journal:  Pharm Res       Date:  2012-05-24       Impact factor: 4.200

2.  Formulation study of topically applied lotion: in vitro and in vivo evaluation.

Authors:  Syed Nisar Hussain Shah; Talib Hussain; Ikram Ullah Khan; Sajid Asghar; Yasser Shahzad
Journal:  Bioimpacts       Date:  2013-01-26

3.  Variability of Skin Pharmacokinetic Data: Insights from a Topical Bioequivalence Study Using Dermal Open Flow Microperfusion.

Authors:  Manfred Bodenlenz; Thomas Augustin; Thomas Birngruber; Katrin I Tiffner; Beate Boulgaropoulos; Simon Schwingenschuh; Sam G Raney; Elena Rantou; Frank Sinner
Journal:  Pharm Res       Date:  2020-09-28       Impact factor: 4.200

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.